by University of Portsmouth A new drug, known as IP1867B, could be used for future treatments of brain tumours. Dr. Richard Hill led the research team at the Brain Tumour Research Centre at University of Portsmouth, working with the University of Algarve (Portugal), the University of Liverpool (UK) and Innovate Pharmaceuticals to examine IP1867B. The research team showed that IP1867B...
Tag: <span>cancer therapies</span>
Post
A new molecule to boost modern cancer therapies
Posted Today Highly effective modern cancer therapies rely on immune cells to attack and shrink tumours. Medicine instructs body’s immune system to attack cancer cells, which is a safer approach, but scientists from the University of Edinburgh found a way to boost this effect. They found a molecule that boosts the function of immune cells and allows patient’s body to launch a powerful anti-cancer immune response. The molecule is...
Post
Diving into the details: A lipid-binding pocket is a target for new cancer therapies
Understanding the molecular details of protein function allows researchers to identify critical residues that can be targeted with rational drug design to develop better cancer therapeutics MEDICAL UNIVERSITY OF SOUTH CAROLINA Normal cells have a complex system of checks and balances that regulate cell division. In cancer, the balance is tipped in favor of cell proliferation. This imbalance arises from...
Post
Scientists home in on microRNA processing for novel cancer therapies
by Virginia Commonwealth University More than a decade of research on the mda-7/IL-24 gene has shown that it helps to suppress a majority of cancer types, and now scientists are focusing on how the gene drives this process by influencing microRNAs. Published this week in the journal Proceedings of the National Academy of Sciences, the findings...
Post
Bioluminescent deep-sea creatures illuminate the effectiveness of new cancer therapies
A study by scientists at the Keck School of Medicine of USC presents a new, less expensive and more accurate way to engineer and monitor immune-system cancer therapies IMAGE: PREET. M CHAUDHARY, MD, PHD, KECK SCHOOL OF MEDICINE OF USC view more CREDIT: RICARDO CARRASCO III LOS ANGELES – Researchers at the Keck School of...
Post
People willing to trade treatment efficacy for reduced side effects in cancer therapies
When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a study published online in Blood Advances, a Journal of the American Society of Hematology (ASH). The...
Post
Some cancer therapies may provide a new way to treat high blood pressure
WASHINGTON — Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment because although a number of high blood pressure drugs are now available, they work by different mechanisms that are not...
Post
Researchers identify new target, develop new drug for cancer therapies
A model of Penn’s new approach using DQ611 to target PPT1, which inhibits both mTOR and autophagy. Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past...